MedTrace Logo

Evaluation of the Intravenous Tissue Plasminogen Activator Treatment Algorithm of Nursing Intern Students

NCT05462665 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2022-07-18

No results posted yet for this study

Summary

Intravenous (IV) tissue plasminogen activator (tPA) is one of the key elements of acute ischemic stroke. In this study, acute stroke patients maximum benefit from the treatment, intravenous tissue plasminogen activator (IV tPA) minimizing the errors related to the treatment of acute ischemic stroke patients of nursing students from clinical practice guides published on the treatment of It is aimed to be informed and to standardize nursing interventions.

Conditions

  • Acute Stroke

Interventions

BEHAVIORAL

theory training

theory training

BEHAVIORAL

theory and simulation training

theory and simulation training

Sponsors & Collaborators

  • Dokuz Eylul University

    lead OTHER

Principal Investigators

  • GULSAH GUROL ARSLAN · DOKUZ EU

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-01
Primary Completion
2022-03-01
Completion
2022-03-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05462665 on ClinicalTrials.gov